查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1801833

ATP 檢測市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

ATP Assay Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 138 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年，全球ATP檢測市場規模達35億美元，預計2034年將以7.6%的複合年成長率成長，達到72億美元。慢性病負擔的加重、個人化治療需求的不斷成長以及檢測技術的持續創新，加速了市場的成長。光度法和酶促檢測平台的演進顯著提高了通量、精確度和靈敏度，從而擴大了其在研究、診斷和藥物開發領域的應用。諸如分光光度計和高通量光度計等增強型實驗室儀器，有助於簡化工作流程並提高檢測效率。

ATP 檢測市場 - IMG1

ATP 檢測對於檢測三磷酸腺苷水平至關重要，而三磷酸腺苷水平是細胞活力、能量代謝和細胞毒性反應的指標。隨著精準醫療和生物相關檢測的興起，對即時細胞檢測的需求日益成長。這些檢測使研究人員能夠在早期藥物開發、環境監測和毒性篩選過程中評估細胞行為、活力和壓力反應。生物技術和製藥實驗室對標靶藥物發現和高通量篩選的日益重視，進一步提升了 ATP 檢測在提供可靠且可擴展的生物資料方面的作用，而這些數據對於下一代療法至關重要。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 35億美元
預測值 72億美元
複合年成長率 7.6%

2024年，耗材市場規模達21億美元，預估到2034年將達45億美元，複合年成長率為7.7%。由於對常規操作所必需的檢測試劑盒、試劑和專用實驗室材料的持續需求，該市場仍將佔據主導地位。這些產品構成了大多數ATP檢測工作流程的支柱，並且在多個平台上都至關重要，尤其是在藥物篩檢和污染檢測領域。隨著實驗室規模的擴大，這些材料在研究和診斷應用中的持續使用將支持該市場的穩定成長。

2024年，光度測定法佔據41.2%的市佔率。其廣泛應用源自於其高精度、快速結果和自動化相容性。這些檢測方法能夠提供高靈敏度和低背景雜訊的定量資料，使其成為大規模篩選和實驗室工作流程的首選。由於其易於與自動化系統整合、即時監控和連接複用功能，它們被廣泛應用於高容量研究環境。它們能夠有效率地處理大量資料集，最大限度地減少手動操作，從而顯著提高吞吐量，同時保持資料一致性。

2024年，北美ATP檢測市場佔據42.5%的市佔率。該地區先進的科研基礎設施、強大的製藥和生物技術公司以及對新型診斷技術的快速應用，持續推動市場需求。美國和加拿大實驗室對細胞檢測、藥物開發和污染檢測的需求日益成長，鞏固了該地區的領先地位。慢性病病例的激增以及臨床試驗投資的不斷增加，也促進了ATP檢測在學術和工業領域的應用不斷成長。

推動全球 ATP 檢測市場的頂級公司包括丹納赫、3M 公司、普羅麥格公司、默克和賽默飛世爾科技，共佔全球市場佔有率的 55%。 ATP 檢測市場的主要參與者正致力於透過在檢測靈敏度、可擴展性和自動化相容性方面的持續研發來實現創新驅動的成長。公司正在透過整合先進的發光技術和支援高通量應用的微孔板系統來增強其產品線。與生技公司和研究機構的策略合作有助於擴大最終用戶群，同時增強品牌知名度。併購也被用來進入新的地理市場並提高生產能力。該公司正在增加對數位實驗室解決方案和基於雲端的分析的投資，以提供更好的檢測監控和資料可追溯性。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 慢性病負擔加重
      • 對細胞檢測的需求不斷成長
      • 生物製藥研發的成長
      • 檢測形式的技術進步
    • 產業陷阱與挑戰
      • 高級套件成本高昂
      • 嚴格的監管準則
    • 市場機會
      • 衛生和環境監測的爆炸性成長
  • 成長潛力分析
  • 監管格局
  • 技術進步
    • 當前的技術趨勢
    • 新興技術
  • 供應鏈分析
  • 2024年定價分析
  • 未來市場趨勢
  • 差距分析
  • 報銷場景
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
    • 北美洲
    • 歐洲
    • 亞太地區
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 關鍵進展
    • 併購
    • 夥伴關係和合作
    • 新產品發布
    • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 - 2034 年

  • 主要趨勢
  • 儀器
    • 光度計
    • 分光光度計
  • 耗材
    • 試劑和試劑盒
    • 微孔板
    • 其他耗材

第6章：市場估計與預測：按檢測類型，2021 - 2034 年

  • 主要趨勢
  • 光度法 ATP 測定
  • 酶促 ATP 測定
  • 生物發光共振能量轉移（BRET）ATP測定
  • 基於細胞的ATP測定
  • 其他檢測類型

第7章：市場估計與預測：按應用，2021 - 2034 年

  • 主要趨勢
  • 藥物發現與開發
  • 污染測試
  • 疾病檢測

第8章：市場估計與預測：依最終用途，2021 - 2034 年

  • 主要趨勢
  • 製藥和生物技術公司
  • 醫院和診斷實驗室
  • 學術和研究機構

第9章：市場估計與預測：按地區，2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第10章：公司簡介

  • 3M Company
  • AAT Bioquest
  • Abcam
  • Agilent Technologies
  • Berthold Technologies
  • Biotium
  • BioVision
  • Cayman Chemical
  • Cell Signaling Technology
  • Charm Sciences
  • Danaher Corporation
  • Lonza
  • Merck
  • PCE Instruments
  • Promega
  • Reddot Biotech
  • Revvity
  • Thermo Fisher Scientific
簡介目錄
Product Code: 14569

The Global ATP Assay Market was valued at USD 3.5 billion in 2024 and is estimated to grow at a CAGR of 7.6% to reach USD 7.2 billion by 2034. Market growth is being accelerated by the rising burden of chronic diseases, the growing demand for personalized therapies, and continuous innovation in assay technology. The evolution of luminometric and enzymatic detection platforms is significantly improving throughput, precision, and sensitivity, resulting in expanded use across research, diagnostics, and pharmaceutical development. Enhanced lab instrumentation, like spectrophotometers and high-throughput luminometers, is helping streamline workflows while increasing assay efficiency.

ATP Assay Market - IMG1

ATP assays are essential for detecting adenosine triphosphate levels, which act as indicators of cellular viability, energy metabolism, and cytotoxic response. With the shift toward precision medicine and biologically relevant testing, demand for real-time, cell-based assays is rising. These tests enable researchers to assess cellular behavior, viability, and stress responses during early drug development, environmental monitoring, and toxicity screening. The growing emphasis on targeted drug discovery and high-throughput screening in biotechnology and pharmaceutical labs continues to elevate the role of ATP assays in delivering reliable and scalable biological data essential for next-generation therapeutics.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.5 Billion
Forecast Value$7.2 Billion
CAGR7.6%

In 2024, the consumables segment generated USD 2.1 billion and will reach USD 4.5 billion by 2034 at a CAGR of 7.7%. This segment remains dominant due to the recurring need for assay kits, reagents, and specialized lab materials essential for routine procedures. These items form the backbone of most ATP testing workflows and are vital across multiple platforms, particularly in drug screening and contamination detection. As laboratories scale their operations, the continued use of these materials in research and diagnostic applications supports steady segmental growth.

The luminometric assays segment held 41.2% share in 2024. Their widespread adoption stems from high accuracy, fast results, and automation compatibility. The ability of these assays to deliver quantitative data with high sensitivity and low background noise makes them the preferred choice for large-scale screening and laboratory workflows. They are widely used in high-volume research settings for their easy integration with automated systems, real-time monitoring, and multiplexing capabilities. Their efficiency in handling large datasets with minimal manual processing significantly improves throughput while maintaining data consistency.

North America ATP Assay Market held 42.5% share in 2024. The region's advanced infrastructure for research, strong presence of pharmaceutical and biotech firms, and rapid uptake of novel diagnostic technologies continue to drive demand. A growing need for cell-based testing, drug development, and contamination detection across labs in the U.S. and Canada has strengthened the region's leadership. The surge in chronic illness cases and expanding investments in clinical trials also contribute to the rising use of ATP assays across academic and industrial sectors.

Top companies driving the Global ATP Assay Market include Danaher, 3M Company, Promega Corporation, Merck, and Thermo Fisher Scientific-together accounting for 55% of global market share. Key players in the ATP assay market are focusing on innovation-driven growth through continuous R&D in assay sensitivity, scalability, and automation compatibility. Companies are enhancing their product lines by integrating advanced luminometric technologies and microplate-based systems that support high-throughput applications. Strategic collaborations with biotech firms and research institutes help expand their End user base while strengthening brand recognition. Mergers and acquisitions are also being used to enter new geographic markets and enhance production capacity. Firms are increasingly investing in digital lab solutions and cloud-based analytics to offer better assay monitoring and data traceability.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product type trends
    • 2.2.3 Assay type trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising burden of chronic diseases
      • 3.2.1.2 Growing demand for cell-based assays
      • 3.2.1.3 Growth in biopharmaceutical R&D
      • 3.2.1.4 Technological advancements in assay formats
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced kits
      • 3.2.2.2 Stringent regulatory guidelines
    • 3.2.3 Market opportunities
      • 3.2.3.1 Explosive growth in hygiene and environmental monitoring
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological advancements
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Supply chain analysis
  • 3.7 Pricing analysis, 2024
  • 3.8 Future market trends
  • 3.9 Gap analysis
  • 3.10 Reimbursement scenario
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 Asia Pacific
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Instruments
    • 5.2.1 Luminometers
    • 5.2.2 Spectrophotometers
  • 5.3 Consumables
    • 5.3.1 Reagents and kits
    • 5.3.2 Microplates
    • 5.3.3 Other consumables

Chapter 6 Market Estimates and Forecast, By Assay Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Luminometric ATP assays
  • 6.3 Enzymatic ATP assays
  • 6.4 Bioluminescence resonance energy transfer (BRET) ATP assays
  • 6.5 Cell-based ATP assays
  • 6.6 Other assay types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Drug discovery and development
  • 7.3 Contamination testing
  • 7.4 Disease detection

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Pharmaceutical and biotechnology companies
  • 8.3 Hospital and diagnostic laboratories
  • 8.4 Academic and research institutes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 3M Company
  • 10.2 AAT Bioquest
  • 10.3 Abcam
  • 10.4 Agilent Technologies
  • 10.5 Berthold Technologies
  • 10.6 Biotium
  • 10.7 BioVision
  • 10.8 Cayman Chemical
  • 10.9 Cell Signaling Technology
  • 10.10 Charm Sciences
  • 10.11 Danaher Corporation
  • 10.12 Lonza
  • 10.13 Merck
  • 10.14 PCE Instruments
  • 10.15 Promega
  • 10.16 Reddot Biotech
  • 10.17 Revvity
  • 10.18 Thermo Fisher Scientific